Bio-Techne (TECH)
52.65
0.00 (0.00%)
Upcoming Events
Latest Headlines
Form 4 BIO-TECHNE Corp For: Jun 02 Filed by: Crouse Steven C.
June 4, 2026 4:29 PM - SEC Filing
Bio-Techne and Refeyn launch integrated workflow for antibody analysis
June 4, 2026 6:31 AM - StreetInsider
Bio‑Techne and Refeyn Close Critical Gap in Bispecific Antibody and Biosimilar Characterization
June 4, 2026 6:30 AM - PR NewsWire
Form SD BIO-TECHNE Corp
June 1, 2026 4:31 PM - SEC Filing
RBC Capital Assumes Bio-Techne Corp. (TECH) at Outperform
May 14, 2026 4:12 PM - StreetInsider
Form 4 BIO-TECHNE Corp For: May 08 Filed by: Herr Amy E.
May 12, 2026 4:04 PM - SEC Filing
Form 144 BIO-TECHNE Corp Filed by: Herr Amy E.
May 8, 2026 4:23 PM - SEC Filing
Form 4 BIO-TECHNE Corp For: May 05 Filed by: Hippel James
May 7, 2026 5:26 PM - SEC Filing
Form 4 BIO-TECHNE Corp For: May 05 Filed by: Bohnen Shane
May 7, 2026 5:25 PM - SEC Filing
Form 4 BIO-TECHNE Corp For: May 05 Filed by: Kelderman Kim
May 7, 2026 5:22 PM - SEC Filing
Bio-Techne Corp. (TECH) PT Lowered to $62 at Wells Fargo
May 7, 2026 8:25 AM - StreetInsider
Bio-Techne Corp. (TECH) PT Lowered to $50 at Stifel
May 7, 2026 7:30 AM - StreetInsider
Bio-Techne Corp. (TECH) PT Lowered to $49 at Baird
May 7, 2026 7:11 AM - StreetInsider
Form 10-Q BIO-TECHNE Corp For: Mar 31
May 6, 2026 4:32 PM - SEC Filing
Form SCHEDULE 13G BIO-TECHNE Corp Filed by: FMR LLC
May 6, 2026 11:01 AM - SEC Filing
Bio-Techne (TECH) Misses Q3 EPS by 1c
May 6, 2026 6:33 AM - StreetInsider
Form 8-K BIO-TECHNE Corp For: May 06
May 6, 2026 6:31 AM - SEC Filing
Bio-Techne Releases Third Quarter Fiscal 2026 Results
May 6, 2026 6:30 AM - PR NewsWire
Bio-Techne Declares Dividend
May 6, 2026 6:30 AM - PR NewsWire
Bio-Techne (TECH) Declares $0.08 Quarterly Dividend; 0.6% Yield
May 6, 2026 6:30 AM - StreetInsider
Form 4 BIO-TECHNE Corp For: May 01 Filed by: Crouse Steven C.
May 5, 2026 4:13 PM - SEC Filing
Bio-Techne to Present at the Bank of America Securities 2026 Global Healthcare Conference
May 4, 2026 7:00 AM - PR NewsWire
Form SCHEDULE 13G BIO-TECHNE Corp Filed by: VANGUARD CAPITAL MANAGEMENT LLC
April 29, 2026 5:01 PM - SEC Filing
Form 4 BIO-TECHNE Corp For: Apr 22 Filed by: Kelderman Kim
April 24, 2026 6:06 PM - SEC Filing
Form 4 BIO-TECHNE Corp For: Apr 22 Filed by: Hippel James
April 24, 2026 6:06 PM - SEC Filing
Form 4 BIO-TECHNE Corp For: Apr 14 Filed by: Kelderman Kim
April 16, 2026 4:20 PM - SEC Filing
Bio-Techne Introduces Streamlined Brand Architecture to Help Customers Navigate Solutions Faster and With Greater Clarity
April 16, 2026 8:00 AM - PR NewsWire
Bio-Techne to Host Conference Call on May 6, 2026, to Announce Third Quarter Fiscal 2026 Financial Results
April 14, 2026 7:00 AM - PR NewsWire
Bio-Techne Corp. (TECH) PT Lowered to $65 at TD Cowen
April 13, 2026 8:42 AM - StreetInsider
Form 4 BIO-TECHNE Corp For: Apr 03 Filed by: Bohnen Shane
April 7, 2026 4:59 PM - SEC Filing
Bio-Techne Corp. (TECH) PT Lowered to $54 at Evercore ISI
April 6, 2026 8:29 AM - StreetInsider
Form SCHEDULE 13G/A BIO-TECHNE Corp Filed by: VANGUARD GROUP INC
March 26, 2026 4:11 PM - SEC Filing
Bio-Techne expands COMET spatial biology platform with new tools
March 25, 2026 6:31 AM - StreetInsider
Bio-Techne Advances Spatial Biology with Modular Expansion of COMET™ Suite
March 25, 2026 6:30 AM - PR NewsWire
Evercore: ' Latest Survey Work Positions 2026 As Better Year For Biopharma Spending'
March 20, 2026 6:05 AM - StreetInsider
TD Cowen: 'MSFT's AI-Powered Spatial Product Weakens Spatial Exposed Stocks'
March 17, 2026 8:56 AM - StreetInsider
TD Cowen on Bio-Techne Corp. (TECH): 'Sell-Off Looks Overdone, We'd Be Buyers on Today's Weakness'
March 17, 2026 8:47 AM - StreetInsider
Bio-Techne Corp. (TECH) PT Raised to $68 at Argus
March 12, 2026 6:53 AM - StreetInsider
Full Article List
